Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07317349

The Effect of a Continuous 1-Hour Time Delay on Circadian Rhythms

The purpose of this study is to investigate whether the experience of a daily time delay can affect our internal circadian rhythm.

Recruiting

Interested in participating?

Request Info

Key information

Age range

23 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aarhus University, Department of Psychology and Behavioural Sciences

Aarhus, 8000, Denmark

Location status: Recruiting

Location contact

Ali Amidi, PhD

SUB_INVESTIGATOR

Alisha Guyett Guyett, PhD

CONTACT

[email protected]

+4587152078

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy adults aged 23-45 years
  • Part of a heterosexual, cohabiting couple willing to participate together in a five-day in-laboratory study
  • Both partners meet all inclusion criteria
  • Completion of at least upper-secondary education
  • Maintain a regular sleep-wake schedule
  • Habitual sleep timing within a normative range (non-extreme chronotype), assessed using the Morningness-Eveningness Questionnaire (MEQ) or the Munich Chronotype Questionnaire (MCTQ)
  • Both partners fall within the acceptable chronotype range to ensure aligned sleep-wake patterns
  • Low seasonality scores on the Seasonal Pattern Assessment Questionnaire (SPAQ)
  • Free from underlying sleep or mood disorders

Exclusion criteria

  • Engages in night-shift work or maintains an irregular work or sleep schedule
  • International travel involving a time-zone change of more than two hours within the past two months, or anticipated travel before study completion
  • Diagnosed neurological, psychiatric, or sleep disorder (e.g., insomnia, sleep apnea, bipolar disorder)
  • High risk of sleep apnea, defined as a Berlin Questionnaire score >2 (Lauritzen et al., 2018)
  • Use of medications known to affect sleep, alertness, melatonin secretion, or circadian timing
  • Unable or unwilling to comply with behavioral restrictions, including refraining from electronic devices displaying time cues unless clocks are removed and devices are disconnected from Wi-Fi
  • Unable or unwilling to comply with consumption restrictions, including abstaining from caffeine, alcohol, and melatonin-rich foods during the study
  • Extreme chronotype, defined as a habitual midsleep time outside 03:00-05:00 on the MCTQ or classification as an extreme morning or extreme evening type on the MEQ
  • Daily caffeine consumption exceeding 400 mg (approximately 4-5 cups of coffee)
  • Current smoker or smoking within the past six months

Treatment and study plan

Fixed daily routine

Behavioral

All activities occur at the same time every day

Daily time delay

Behavioral

All activities will be delayed by one hour per day over a 5 day period.

Primary outcomes

  1. Phase shift in circadian rhythm markers

    Time frame: Comparing samples on days 1, 3, 5

    The primary outcome is the timing of dim light melatonin onset, a marker of circadian phase. Saliva samples will be collected at regular intervals under dim light, and the time when melatonin exceeds 3 pg/mL will be recorded for each participant. This allows measurement of circadian phase shifts across conditions.

Secondary outcomes

  1. Psychomotor Vigilance Task (PVT) Median Reaction Time

    Time frame: Performance will be measured at regular intervals on days 1 - 5 to track changes over the course of the study.

    Median reaction time (milliseconds) on a brief psychomotor vigilance task (PVT) six times each day. Participants respond as quickly as possible to visual stimuli presented at random inter-stimulus intervals. For each block, the median reaction time is computed; additional indices such as lapses (responses > 500 ms) may be derived. Changes in PVT performance across the the 5 days are analysed in relation to circadian phase.

Study contacts

Contact information is provided by the study sponsor or research team.

Ali Amidi, PhD

CONTACT

[email protected]

+4587165305

Alisha Guyett, PhD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Collaborators

  • Independent Research Fund Denmark

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Jan 5, 2026
Registry last updated
Jan 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.